semaglutide 12.5mg/2.5ml FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Vials:1 without Not all compounded GLP-1

semaglutide 12.5mg/2.5ml FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Vials:1 without Not all compounded GLP-1

Not all compounded GLP-1 medications are the same. There are real differences in: • Quality and sourcing • Compounding standards • Pricing structures • Pharmacy oversight At Riverside Pharmacy, we believe patients

Between the pharmacological options, the GLP-1RA, originally approved for the treatment of DM2, have been demonstrated to be useful for body weight reduction in obese individuals

without

Vials:1

It focused exclusively on participants with overweight or obesity who did not have diabetes (because weight loss in obesity drug trials is always lower in people with diabetes than without – thus results cannot be compared or mixed)